INTRODUCTION

C
erebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary early-onset vascular disease causing recurrent ischemic subcortical infarcts, generally accompanied by migraine, cognitive impairment, psychiatric symptoms and progressively severe neurologic deficits. 1, 2 Several methods for diagnosing CADASIL have been proposed. The first Magnetic Resonance Imaging (MRI) characteristics of CA-DASIL were described in 1991. 3, 4 Generally, they reveal areas of T1 hypointensity and hyperintensity on T2 and FLAIR (Fluid Attenuation Inversion Recovery) images in subcortical white matter, initially affecting temporal lobes and external capsules and spreading to other regions, as well as the presence of lacunar infarcts. 5, 6 Practically all patients manifest the condition before the age of 60 years, while changes on MRI have been detected in individuals younger than 35 years. 4 In addition, the presence of Granular Osmiophilic Material (GOM) in capillary blood vessels of the skin and muscle on biopsy and genetic studies (Notch 3 analysis) play a key diagnostic role. Biopsy exams have high specificity (up to 100%) yet low sensitivity (less than 50%). Notch 3 testing has been proposed as the primary diagnostic approach, allowing the detection of 90% of affected individuals.
CASE REPORT
A 52-year-old man, right-handed, with ten years of schooling and positive family history for CADASIL, was attended at our service in 2008. He is both hypertensive and diabetic. The patient presented with a blood pressure (BP) of 200 × 120 mm/Hg and glycemia of 800 mg/d at the first stroke episode. Currently, he is in use of the medications Co-Renitec and Amaryl D 4 mg, controlling both BP and glycemia at normal levels.
The presence of these risk factors makes this case of special interest, showing the importance diagnostic confirmation by genotyping, with regard to differential diagnosis.
The disease initially manifested with transitory ischemic attacks (TIA) followed by sensitivity symptoms (paresthesia) and motor signs (faciobrachiocrural hemiparesis) to the left side. The patient reported episodes of migraine preceded by visual aura. Clinical evolution was rapid and progressive with the emergence of cognitive impairment and worsening motor picture.
Neuropsychological assessment was carried out by applying the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) 8 battery, which includes the Mini-Mental State Examination (MMSE) validated for use in Brazil 9 and complementary tests focusing on executive function -the Trail-Making Tests (A and B) (TMT-A and TMT-B), 10 the Clock Completion Test (CCT) (maximum errors: 7, normal: 0 to 3 and abnormal: 4 to 7), 11 the Complex Figure Copying Test, 12 Gesture Imitation 12 and the version of the Clinical Dementia Rating (CDR) 13 scale validated for use in Brazil. 14 No formal test was applied to assess functional independence. However, an interview focusing on occupational aspects and activities of daily living (ADL), including the conducting and handling of personal finances, was conducted with the patient reporting no significant functional problems, a finding corroborated by at least one family member.
The results of the neuropsychological assessment showed changes, as shown in Table 1 .
The patient was submitted to MRI which revealed, on FLAIR, extensive areas of hypersignal in subcortical white matter, predominantly frontal, temporal and parietal, in addition to compromised external and internal capsules, brain stem and presenting lacunar infarcts in the temporal and right parietal regions ( Figure 1 ).
Morphometric analysis was also performed using segmentation by the signal intensity technique, evidencing the percentage of frontal lobe lesions (41.8%) ( Table 2) .
Genetic analysis was carried out (Laboratoire Géné-tique Moléculaire de l' Hôpital Lariboisière -Paris, Prof. Elisabeth Tournier-Lasserve) based on the direct DNA sequencing of exons 3 and 4 of the Notch 3 gene (chro- mosome 19), which revealed a nucleotide substitution of Arginine (CGC) to Cysteine (TGC) at position 153 in exon 4 (c.535 C >T: R153C), consistent with CADASIL diagnosis, confirming the etiology of the disease. Three of his siblings were later confirmed as carrying the same mutation. Recently, these individuals were included in a study assessing cognitive and neuroimaging profile.
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DISCUSSION
Four large studies encompassing a total of 175 individuals have investigated the profile of cognitive decline in CADASIL. 16, 17 Of these studies, two focused on the relationship of the age effect and disease stage with cognitive profile. 17, 18 In the present case, changes were evident in global performance (MMSE) and in language, memory, apraxia and executive function domains.
In the language domain, both semantic verbal fluency (animals category) and naming ability were compromised. Deficit in verbal fluency is frequently observed in studies on CADASIL. 16, 19 In the study by Buffon et. al., 18 verbal fluency (semantic category) was found to be reduced.
Memory showed compromised register/learning yet better performance for recognition compared to spontaneous recall. Memory in patients with CADASIL tends to by relatively preserved, where patients may present compromise in immediate memory and free recall. On the other hand, both recall with cues and recognition are invariably preserved, suggesting that the encoding process is preserved. 16, 19 Results on the Complex Figure Copying and Gesture Imitation tests revealed the presence of constructional and ideomotor apraxia, respectively. This finding may be of particular importance given that it has been little discussed in the specialized literature. Some studies 20 have reported ideomotor apraxia in 15% of individuals with lesions confined to the thalamic or lenticular region. Ragno et. al., 21 studied 12 individuals from two families and found that only one had deficit in ideomotor apraxia. Trojano et. al., 22 suggested that constructional and ideomotor apraxia can appear in some patients with cortical lesions. Peter et al., 23 in search of evidence, carried out a meta-analysis of reports published in the literature between 1994 and 1996, which included 82 patients and focused on apraxias associated with lesions in deep brain structures, such as the basal ganglia, thalamus and internal capsule. The study revealed that lesions to periventricular deep white matter play a crucial role in the development of apraxias, particularly ideomotor.
Executive function was also impaired, evidenced by reduced verbal fluency, planning difficulties and problems in space usage on the Clock Completion Test, slowness on the TMT-A (also reflecting attention deficit), incomplete TMT-B (also reflecting deficit in shifts in attention) and TMT-B/TMT-A >3, suggesting impaired cognitive flexibility. In line with findings of previous studies, executive dysfunction was clearly evident. Buffon et al., 18 in a study of 42 individuals with CADASIL, found executive dysfunction in almost 90% of individuals under 50 years of age, and suggested this finding may be explained by a decline in attention and memory performance consistent with some degree of frontal subcortical dysfunction.
Despite concerted research efforts, the mechanisms underlying cognitive dysfunction in CADASIL remain unclear. However, evidence suggests these mechanisms may be related to disruption of corticosubcortical/or corticocortical connections due to progressive damage to white matter 18 and that cognitive decline in CADASIL is likely related to accumulated lacunar infarcts and augmented ventricular volume, but not to brain atrophy 24, 25 .
A B Conclusion. The CADASIL case reported, in addition to exhibiting a characteristic neuroimaging pattern, was diagnostically confirmed by Notch-3 gene analysis. The neuropsychological findings were consistent with those reported in the literature, most notably the presence of apraxias, seldom mentioned in the specialized literature.
It is hoped that this individual and the other members of this and other families can benefit from the future development of protocols for pharmacological intervention and cognitive rehabilitation.
